{"disease":{"id":"liver-injury-drug-induced","name":"liver injury drug induced"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06670391","title":"A Retrospective Study in Patients With Liver Injury After the Use of Novel Antineoplastic Agents","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Drug Induced Liver Disease Study Group","has_results":false},{"nct_id":"NCT04269486","title":"A Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient Setting","phase":"","overall_status":"TERMINATED","enrollment_count":287,"lead_sponsor_name":"Korea Institute of Oriental Medicine","has_results":false},{"nct_id":"NCT03069820","title":"Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Second Affiliated Hospital of Nanchang University","has_results":false},{"nct_id":"NCT03667157","title":"Liver Function After Intravenous Methylprednisolone Administration","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT06285253","title":"miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Miromatrix Medical Inc.","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}